Choosing a Remote Dermatology Service

Teledermatology services range from board-certified dermatologists running structured photo workflows to platforms where it is not entirely clear who you are interacting with. The clinical questions are similar across services; the operational details — credentialing, biopsy paths, follow-up — are where the differences live.

The short version

Verify board certification at certificationmatters.org. ABMS-recognized dermatology certification means a residency-trained dermatologist.
Some platforms use board-certified dermatologists; some use a mix that includes PAs, NPs, or non-dermatology clinicians. Both can work; opacity is a problem.
Async (photo-and-message) is fast and cheap; live video is slower but better suited to new and complex problems.
Biopsy logistics — how a service handles a lesion that needs tissue diagnosis — separates real practices from marketing operations.
Prescription handling for retinoids, topicals, biologics, and isotretinoin (which has FDA iPLEDGE requirements) varies.
Follow-up cadence and continuity matter for chronic conditions like acne, eczema, and psoriasis.

Who is reviewing your photos

The most opaque question in teledermatology is who actually evaluates the photos. Some services use only board-certified dermatologists. Some delegate first review to dermatology PAs or NPs, with dermatologist sign-off. Some use generalist clinicians with skin training. None of these is necessarily wrong, but you should know which one you are getting.

Verification is straightforward. The American Board of Medical Specialties' public portal at certificationmatters.org confirms whether a specific physician is board-certified in dermatology. State medical and licensing boards verify license status and any disciplinary history for clinicians broadly. A platform that does not list specific clinicians, or whose listed clinicians do not match the people you actually interact with, is a flag. See dermatology remotely.

Async, live, or hybrid

Async (store-and-forward)

You upload photos and a description; a clinician responds within hours to a day. Cheaper, faster, and well-suited to stable conditions and follow-ups. The clinician does not interact with you in real time, which limits the back-and-forth on nuanced new presentations.

Live video

You meet with a clinician on a video call. Slower to schedule and more expensive but better for new problems, complex presentations, and care that requires discussion of treatment plans.

Hybrid

Many services combine async for routine follow-ups with live for new evaluations or escalations. This is often the most useful structure.

Match the modality to your situation. New, complex, or atypical: live, or in-person if the platform recommends it. Stable acne or eczema follow-up: async is fine.

Biopsy logistics: the practical test

Sooner or later, a teledermatology relationship encounters a lesion that needs a biopsy. How a platform handles this is the cleanest test of whether it is a clinical practice or a marketing operation. Reasonable models:

An owned or affiliated network of in-person clinics.
A national network of partner dermatologists who accept referrals for biopsy.
Relationships with national pathology labs and standard kits.
Clear instructions for working with your own primary care or local dermatologist for the procedure.

A service that handles a "needs biopsy" finding by simply telling you to "see a local dermatologist" without any path is shifting work to you and is a flag.

Prescription handling

Most dermatology medications are non-controlled and prescribable remotely without difficulty: topical retinoids, topical antibiotics, oral antibiotics for acne, biologics for psoriasis, hormone therapy for acne, antifungals. Specific cases:

Isotretinoin: The FDA's iPLEDGE risk evaluation and mitigation strategy program has specific patient registration and monthly visit requirements. Some teledermatology services manage isotretinoin within iPLEDGE; others refer.
Biologics: Many services prescribe biologics for psoriasis or atopic dermatitis. The medications often require specialty pharmacy distribution, prior authorization, and sometimes baseline labs.
Compounded products: Some teledermatology platforms rely on compounded topicals. These are sometimes useful, but a default to compounded products when an FDA-approved option exists deserves a question.

Follow-up and continuity

For chronic conditions — acne, eczema, psoriasis, rosacea, hair loss — care extends over months to years. The platform's follow-up cadence and continuity matters. Useful patterns:

Scheduled follow-ups at appropriate intervals for the condition (more frequent during initiation; less frequent when stable).
Same clinician across follow-ups when possible.
Visit notes available in the patient portal.
Ability to reach the clinician between visits with a defined response time.
Coordination with primary care or other specialists when needed.

Photo quality is your variable

Photo quality is the single biggest determinant of whether a remote dermatology visit produces a useful answer. The platform can do everything right and still be unable to help if the photos are blurry, dim, or wrong. The page on photographing skin conditions covers the technique. The summary: natural daylight, no flash, three distances, scale reference.

Skin of color

Conditions can present differently across skin tones, and clinical training has not historically emphasized presentation in skin of color. A teledermatology service should have clinicians experienced in evaluating a range of skin tones. For inflammatory conditions and certain cancers that may present differently or be distributed differently across populations, this matters.

Insurance and pricing

Many teledermatology services operate cash-pay; some accept insurance. Pricing should be transparent before you submit photos. Common patterns:

Per-visit cash pricing for an async submission.
Subscription models that bundle a number of visits or unlimited messaging.
Insurance-billed visits at usual specialist rates.

For prescriptions, the cost of the medication itself can substantially exceed the visit cost, especially for biologics. See insurance and telehealth.

What to ask before signing up

Will my photos be reviewed by a board-certified dermatologist? Can I see who specifically?
What is the workflow if you suspect cancer or recommend a biopsy?
What follow-up is included or available?
Do you accept my insurance? What does it cost otherwise?
Are visit notes available in the portal?
How do I get records sent to my primary care or to another dermatologist?
What states are you licensed in?
Do you handle isotretinoin within iPLEDGE? Biologics?

Red flags

No board-certified dermatologists involved, despite "dermatology" branding.
No specific clinician names visible.
No clear path for biopsy referral.
Heavy promotion of compounded products without clinical reason.
Subscription that auto-charges with no clinical interaction.
Refusal to share notes or records.
"Diagnosis" without evaluating photos meaningfully.

See red flags in any remote care service.

When this is not enough

Full-body skin checks for cancer screening are in-person work. New, atypical, changing, or rapidly growing lesions need in-person evaluation. Severe or systemic skin disease, blistering disorders, suspected serious infections — all in-person or emergency. See when telehealth is not enough.

Choosing a remote dermatology service